A Phase 2 Study to Evaluate the Safety and Efficacy of VS-505(AP301) to Treat Hyperphosphatemia in Hemodialysis Patients

Clinical trial NCT04551300 · COMPLETED

Trial details

NCT number: NCT04551300
Sponsor: Shanghai Alebund Pharmaceuticals Limited
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hyperphosphatemia

Start date: 2020-10-13
Primary completion: 2022-06-30
Enrollment: 158

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.